전신 자가면역질환에서 Line Immunoassay를 이용한 항 ENA항체 및 항 dsDNA항체의 검출
Detection of Anti-ENA and anti-dsDNA Antibodies Using Line Immunoassay in Systemic Autoimmune Diseases
2
조회
0
다운로드
3
인용
0
참고문헌
초록
Abstract
Background : Detection of antibodies to extractable nuclear antigens (ENAs) and dsDNA is needed for the diagnosis of and predicting prognosis in systemic autoimmune diseases. Recently introduced line immunoassay (LIA) has the advantage of detecting several autoantibodies simultaneously, and we evaluated its usefulness in the diagnosis of autoimmune diseases in comparison with enzyme-linked immunosorbent assay (ELISA). Methods : Samples were collected from 437 patients referred by rheumatologists. FANA (fluorescent antinuclear antibody) test and LIA for the detection of 13 different autoantibodies, including 6 ENAs and dsDNA were performed. LIA-positive samples for ENA or dsDNA antibodies were further tested with ELISA. Final diagnosis was made by rheumatologists according to the diagnostic criteria. Agreement of results between LIA and ELISA was analyzed in 53 selected patients with systemic autoimmune diseases. Results : The LIA detected antibodies to ENA and dsDNA in 118 and 22 patients, respectively, and ELISA detected 70.3% (83/118) and 45.5% (10/22) of LIA positive samples. Especially, 60.2% (71/118) of patients with positive ENA antibody on LIA was diagnosed as systemic autoimmune diseases. Patients having strong FANA titer and homogenous/speckled pattern showed higher prevalence of autoantibodies, but a small proportion of FANA negative patients also showed positive reactivity (LIA 10.8%, ELISA 5.2%). LIA showed a good agreement with ELISA for the anti-ENA antibodies (≥80%), and a lower agreement for the anti-dsDNA antibody (67.9%). Conclusions : LIA detecting several autoantibodies simultaneously might replace ELISA for anti-ENA antibodies, but not for anti-dsDNA antibodies. When LIA is performed considering clinical manifestations and FANA, it could contribute to the diagnosis of systemic autoimmune disease. (Korean J Lab Med 2008;28:353-61)
참고문헌 (16)
- Reisner BS, "Comparison of an enzyme immunoassay to an indirect fluorescent immunoassay for the detection of antinuclear antibodies", Am J Clin Pathol, 111, pp.503~506 (1999)
- Fenger M, "Detection of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis", Clin Chem, 50, pp.2141~2147 (2004)
- Homburger HA, "Cascade testing for autoantibodies in connective tissue disease", Mayo Clin Proc, 70, pp.183~184 (1995)
- Hoffman IE, "Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests", Clin Chem, 48, pp.2171~2176 (2002)
- Bossuyt X, "Antibodies to extractable nuclear antigens in antinuclear antibody-negative samples", Clin Chem, 51, pp.2426~2427 (2005)
- Delpech A, "Antibodies to Sm, RNP and SSB detected by solid-phase ELISAs using recombinant antigens: a comparison study with counter immunoelectrophoresis and immunoblotting", J Clin Lab Anal, 7, pp.197~202 (1993)
- Lopez-Longo FJ, "Simultaneous identification of various antinuclear antibodies using an automated multiparameter line immunoassay system", Lupus, 12, pp.623~629 (2003)
- Vitali C, "Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group", Ann Rheum Dis, 61, pp.554~558 (2002)
- Hu PQ, "Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis", Arthritis Rheum, 48, pp.1363~1373 (2003)
- Damoiseaux J, "Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens", Ann N Y Acad Sci, 1050, pp.340~347 (2005)
- Rouquette AM, "Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods", Am J Clin Pathol, 120, pp.676~681 (2003)
- Villalta D, "Detection of anti-ENA autoantibodies in patients with systemic connective tissue disease. Analytical variability and diagnostic sensitivity of 4 methods", Recenti Prog Med, 90, pp.579~584 (1999)
- Damoiseaux JG, "From ANA to ENA: how to proceed?", Autoimmun Rev, 5, pp.10~17 (2006)
- Arbuckle MR, "Development of autoantibodies before the clinical onset of systemic lupus eythematosus", N Eng J Med, 349, pp.1526~1533 (2003)
- Sanchez-Guerrero J, "Utility of anti- Sm, anti-RNP, anti-Ro", SS-A, and anti-La, Arthritis Rheum, pp.1996, 39[DOI]
- Vos PA, "Cost-effective detection of non-antidouble- stranded DNA antinuclear antibody specificities in daily clinical practice", Rheumatology, 45, pp.629~635 (2006)